Shigella Flexneri Serotype 3a: the Rise of a Superbug

Overview

Journal Lancet Infect Dis

Specialty Infectious Diseases

Date 2015 May 5

PMID 25936610

Citations 3

Authors

Herve Agaisse

Affiliations

Soon will be listed here.

Citing Articles

On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.

Lyons B, Strynadka N Medchemcomm. 2019; 10(8):1273-1289.

PMID: 31534650 PMC: 6748289. DOI: 10.1039/c9md00146h.

Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type III Secretion System Protein IpaD.

Dey S, Anbanandam A, Mumford B, De Guzman R ChemMedChem. 2017; 12(18):1534-1541.

PMID: 28750143 PMC: 5741093. DOI: 10.1002/cmdc.201700348.

The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America.

Barrantes K, Achi R Braz J Microbiol. 2016; 47(4):800-806.

PMID: 27528086 PMC: 5052361. DOI: 10.1016/j.bjm.2016.07.019.

References

Ison C . Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment. Curr Opin Infect Dis. 2011; 25(1):73-8. DOI: 10.1097/QCO.0b013e32834e9a6a. View

Kotloff K, Winickoff J, Ivanoff B, Clemens J, Swerdlow D, Sansonetti P . Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999; 77(8):651-66. PMC: 2557719. View

DuPont H . Approach to the patient with infectious colitis. Curr Opin Gastroenterol. 2011; 28(1):39-46. DOI: 10.1097/MOG.0b013e32834d3208. View

Musher D, Musher B . Contagious acute gastrointestinal infections. N Engl J Med. 2004; 351(23):2417-27. DOI: 10.1056/NEJMra041837. View

Chang H, Cohen T, Grad Y, Hanage W, OBrien T, Lipsitch M . Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiol Mol Biol Rev. 2015; 79(1):101-16. PMC: 4402963. DOI: 10.1128/MMBR.00039-14. View

Wright G . The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol. 2007; 5(3):175-86. DOI: 10.1038/nrmicro1614. View

. Shigella sonnei outbreak among men who have sex with men--San Francisco, California, 2000-2001. MMWR Morb Mortal Wkly Rep. 2001; 50(42):922-6. View

Grad Y, Kirkcaldy R, Trees D, Dordel J, Harris S, Goldstein E . Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis. 2014; 14(3):220-6. PMC: 4030102. DOI: 10.1016/S1473-3099(13)70693-5. View

Gu B, Cao Y, Pan S, Zhuang L, Yu R, Peng Z . Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Int J Antimicrob Agents. 2012; 40(1):9-17. DOI: 10.1016/j.ijantimicag.2012.02.005. View

10.

Baker K, Dallman T, Ashton P, Day M, Hughes G, Crook P . Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study. Lancet Infect Dis. 2015; 15(8):913-21. DOI: 10.1016/S1473-3099(15)00002-X. View

11.

Barbee L . Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis. 2014; 27(3):282-7. PMC: 4097387. DOI: 10.1097/QCO.0000000000000058. View

12.

Borg M, Modi A, Tostmann A, Gobin M, Cartwright J, Quigley C . Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011. Euro Surveill. 2012; 17(13). View